Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Journal of Neurology|February 21, 2023
Sjögren's syndrome with and without neurological involvementTabea Seeliger, Emelie Kramer, Franz Felix Konen, et al.BMC Infectious Diseases|February 7, 2025
Neuroborreliosis with encephalitis: a broad spectrum of clinical manifestationsDominica Hudasch, Franz Felix Konen, Nora Möhn, et al.Brain Sciences|March 25, 2022
The Influence of the Ventricular-Lumbar Gradient on Cerebrospinal Fluid Analysis in Serial SamplesFranz Felix Konen, Peter Lange, Ulrich Wurster, et al.International Journal of Molecular Sciences|December 2, 2018
The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple SclerosisPhilipp Schwenkenbecher, Franz Felix Konen, Ulrich Wurster, et al.Cells|April 5, 2020
The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in NeuroinflammationFranz Felix Konen, Ulrich Wurster, Torsten Witte, et al.Frontiers in Medicine|May 22, 2026
Muscular involvement in Sjögren's disease is associated with male gender, Ro52 autoantibodies, and a higher clinical activityChristine Gründges, Sabrina Benz, Anna Meinecke, et al.Journal of Neurology|February 21, 2021
CIDP associated with Sjögren's syndromeTabea Seeliger, Stefan Gingele, Lena Bönig, et al.Brain Sciences|April 21, 2022
Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological DiseasesFranz Felix Konen, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, et al.Frontiers in Immunology|September 25, 2025
Idiopathic inflammatory myopathy associated with Sjögren's disease: features of a distinct clinical entityFranz Felix Konen, Yunus Emre Güzeloglu, Tabea Seeliger, et al.Biomedicines|July 27, 2022
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple SclerosisFranz Felix Konen, Malte Johannes Hannich, Philipp Schwenkenbecher, et al.Pageof 6